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The nutrient-sensing metabolite S-adenosylmethionine (SAM)
controls one-carbon metabolism by donating methyl groups to
biochemical building blocks, DNA, RNA, and protein. Our recent
work uncovered a requirement for cytoplasmic arginine methyl-
ation duringWnt signaling through the activity of protein arginine
methyltransferase 1 (PRMT1), which transfers one-carbon groups
from SAM to many protein substrates. Here, we report that
treatments that decrease levels of the universal methyl donor
SAM were potent inhibitors of Wnt signaling and of Wnt-induced
digestion of extracellular proteins in endolysosomes. Thus, arginine
methylation provides the canonical Wnt pathway with metabolic
sensing properties through SAM. The rapid accumulation of Wnt-
induced endolysosomes within 30 minutes was inhibited by the
depletion of methionine, an essential amino acid that serves as the
direct substrate for SAM production. We also found that methio-
nine is required for GSK3 sequestration into multivesicular bodies
throughmicroautophagy, an essential step inWnt signaling activity.
Methionine starvation greatly reduced Wnt-induced endolysosomal
degradation of extracellular serum proteins. Similar results were
observed by addition of nicotinamide (vitamin B3), which serves as a
methyl group sink. Methotrexate, a pillar in the treatment of cancer
since 1948, decreases SAM levels. We show here that methotrexate
blocked Wnt-induced endocytic lysosomal activity and reduced
canonical Wnt signaling. Importantly, the addition of SAM during
methionine depletion or methotrexate treatment was sufficient to
rescue endolysosomal function andWnt signaling. Inhibiting theWnt
signaling pathway by decreasing one-carbon metabolism provides a
platform for designing interventions in Wnt-driven disease.
Wnt signaling | arginine methylation | methotrexate |
S-adenosylmethionine | nicotinamide
Acomplex web of signal transduction events dictates cellulardecisions by coordinating nutrient availability and intracellu-
lar signaling cascades. Canonical Wnt signaling is an evolutionarily
conserved pathway that is intricately regulated (1) to govern a
diverse set of processes through β-catenin activation of the T cell
factor/lymphoid enhancer factor (TCF/LEF) family (2, 3). Re-
cently, it has also been realized that Wnt signaling is an overall
regulator of cellular protein catabolism (1, 4–6).
Glycogen synthase kinase (GSK3) is a key player in the Wnt
pathway, targeting β-catenin for polyubiquitination and degrada-
tion in proteasomes (7, 8). Canonical Wnt stabilizes β-catenin
through the inhibition of GSK3 (5, 9–11). Upon Wnt signaling,
β-catenin becomes stabilized following the sequestration of active
GSK3 from the cytosol inside late endosomes/multivesicular
bodies (MVBs). This translocation is achieved through micro-
autophagy of cytosolic components in small intraluminal vesicles
via the Vacuolar protein sorting/endosomal sorting complexes
required for transport (Vps/ESCRT) machinery (4, 5). Wnt
signaling stabilizes many proteins in addition to β-catenin
through a mechanism known as Wnt-dependent stabilization of
proteins (Wnt/STOP) (4, 5, 12, 13), which facilitates processes
such as cell growth during G2/M in preparation for division (4, 14).
GSK3 is a promiscuous kinase that processively phosphory-
lates consecutive consensus motifs (S/T-XXX-S/T) that are present
in 20% of the human proteome (4, 5, 15, 16). In addition to GSK3,
Wnt signaling also sequesters additional cytosolic proteins, many of
which are GSK3 substrates, into endolysosomes (1, 12) to re-
generate cellular building blocks (17, 18). We and others re-
cently demonstrated that canonical Wnt signaling increases
lysosomal activity and the endocytosis and digestion of extra-
cellular BSA (1, 19). Intriguingly, pancreatic tumor cells adapt to
surrounding microenvironments by acquiring nutrients from
extracellular sources for metabolic reprogramming (20–23).
Whether Wnt signaling through endolysosomes rewires metab-
olism is unknown.
A striking increase in endolysosomes/MVBs occurs within
5 min of Wnt stimulation (1). We recently discovered that pro-
tein arginine methyl transferase 1 (PRMT1) is required for ca-
nonical Wnt to signal and increase endocytosis of extracellular
proteins (1). Of the nine PRMTs, PRMT1 is essential for de-
velopment (24, 25) and accounts for 85% of cellular arginine
methylation (26–28). Importantly, PRMT1 is expressed at high
levels in the Wnt-dependent stem cells of the intestinal crypt
where it is required for proliferation (29, 30) and intestinal
remodeling (31–33).
PRMTs add methyl groups to arginine residues using the uni-
versal methyl-donor, S-adenosylmethionine (SAM, also known as
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AdoMet) as a substrate (28, 29, 34). Present in every living cell,
SAM is known as a hub metabolite as it is used for myriad pro-
cesses (35, 36). In contrast to phosphorylation where the kinase
substrate ATP exists in vast excess, methylation is harmonized
with the metabolic state of the cell as SAM levels are determined
by nutrient availability (37–39). SAM is generated through one-
carbon metabolism, a fundamental metabolic pathway that cou-
ples the folate and methionine cycles to coordinate nutritional
status with physiological processes by transferring methyl groups
to various substrates (40, 41). Within this cycle, SAM is generated
directly from ATP and methionine, an essential amino acid whose
levels are dictated by dietary factors (42–44). The rapid kinetics
provided by posttranslational modifications are essential for reg-
ulating metabolic fluxes. Metabolic and transcriptional networks
operate on different timescales where the turnover of a metabolite
occurs within seconds (23), while Wnt/β-catenin luciferase assays
usually involve periods of 12 h and MVB sequestration takes place
within minutes after Wnt addition (1). Whether one-carbon me-
tabolism influences PRMT1 or Wnt signaling is unknown.
In this study, we show that methionine availability regulates
Wnt signaling by determining cellular SAM levels through one-
carbon metabolism. Elucidating the timescales of cellular events
in this study facilitates an intuitive understanding of these mo-
lecular mechanisms. The findings contribute to the relationship
of Wnt and metabolism by focusing on early membrane traf-
ficking events, supporting a model whereby Wnt signaling me-
diates rapid cellular responses to alterations in nutritional or
environmental status. Importantly, inhibition of canonical Wnt
with the antifolate methotrexate compromised endocytosis and
lysosomal activity. This work reveals a role for the methionine
cycle in fueling endocytosis and Wnt signaling, processes not
previously known to be targeted by methotrexate.
Results
Methionine Is Required for Endocytosis and Wnt Signaling. One-
carbon metabolism is composed of the methionine cycle (Fig. 1A)
and the folate cycle. The methylation cofactor SAM is generated
through the ATP-driven adenylation of methionine by methionine
adenosyltransferase (MAT) enzymes (45). SAM provides the
methyl groups to substrates where PRMTs deposit methyl groups
on the guanidino nitrogen atoms of arginines (28). Methyl transfer
generates S-adenosylhomocysteine (SAH) as a byproduct, which is
rapidly converted to homocysteine (41). Given that methionine
represents an essential substrate upstream of SAM production and
arginine methylation is required for canonical Wnt, we first set out
to examine whether methionine levels affected Wnt signaling.
Wnt3a treatment for 5–30 min generates large endolysosomal
vesicles within the cell (1) that contain cytoplasmic proteins
translocated by microautophagy (5, 12). To examine whether
Wnt-induced vesicles were sensitive to methionine levels, HeLa
cells were incubated in methionine-depleted RPMI culture me-
dium with or without the addition of Wnt3a protein for 30 min
and analyzed by phase contrast microscopy (Fig. 1B). Wnt3a
protein generated the formation of large vesicles (Fig. 1 C and D).
Vesicles also formed in the presence of cycloheximide, indicating
that the Wnt-induced vesicles were not dependent on new protein
synthesis (SI Appendix, Fig. S1 A–D). In methionine-depleted
medium, vesicle formation was inhibited during Wnt activation,
compared with cells incubated with methionine-containing medium
(Fig. 1 E and F). Measurement of phase contrast images further
showed that the Wnt3a-induced vesicles (2–5 μm in diameter) were
greatly decreased or absent in methionine-depleted conditions
(Fig. 1 G and H). Use of either dialyzed or nondialyzed (in-
complete methionine depletion) FCS produced similar results;
nondialyzed FCS was used in the experiments shown in Fig. 1. We
next examined the temporal kinetics of vesicle formation and
found that pretreatment for 30 min in low-methionine medium was
sufficient to decrease Wnt-induced vesicles (Fig. 1I). This rapid
timescale is consistent with a direct sensing mechanism rather than
an indirect effect on de novo protein synthesis (Fig. 1I).
Canonical Wnt signaling requires the sequestration of GSK3
in late endosomes/MVBs (5, 46). Therefore, we next examined
whether methionine starvation affected the vesicular trans-
location of specific Wnt targets using protease protection
assays, the gold standard for analyzing membrane-bounded
organelles (47). Cells were first treated with digitonin, which
permeabilizes the plasma membrane while leaving intracellular
vesicular membranes intact, and then with proteinase K that
degrades cytosolic proteins not protected inside intracellular
membrane-bounded organelles. Wnt3a-treated cells were incubated
in medium with or without methionine, subjected to protease pro-
tection assays, fixed, and stained with anti-GSK3 antibodies. Fol-
lowing Wnt3a treatment, GSK3 was protected from proteinase K
digestion inside vesicular endolysosomal membranes after digitonin
permeabilization (Fig. 1 J and K). In the same conditions but in the
presence of Triton-X 100, GSK3 was completely digested as shown
previously (1). In contrast, methionine starvation dramatically re-
duced vesicular GSK3 relocalization by Wnt3a (Fig. 1M). These ex-
periments indicate that suitable levels of methionine were required
for GSK3 translocation from the cytosol into MVBs.
As GSK3 sequestration is required for canonical Wnt signaling
and β-catenin stabilization (1, 5), we next examined whether
methionine regulates transcriptional activity of the β-catenin–
activated (BAR) Wnt luciferase reporter (48) using HEK293T
cells stably transfected with BAR/Renilla (49). Wnt3a-treated
cells were incubated in RPMI medium with or without methio-
nine, and luciferase activity was measured. Consistent with the
immunofluorescence results above, the loss of GSK3 sequestration
in methionine-depleted medium caused a significant decrease of
BAR luciferase activity (Fig. 1N). We next examined the nature of
this response by reintroducing methionine and found that Wnt
signaling was rescued, indicating that the effects of methionine
depletion were reversible (Fig. 1N, compare lanes 3 and 4). To-
gether, these results revealed that Wnt signaling and endolysosomal
formation are sensitive to the availability of a particular amino
acid, methionine.
The Methionine Cycle Regulates PRMT1 Localization and Endocytosis
During Wnt Signaling. The data above were compatible with a link
between one-carbon metabolism and Wnt signaling. One-carbon
metabolism is required for arginine methylation, a reversible
posttranslational modification that occurs almost as frequently
as phosphorylation (50). Work from the E.M.D.R. laboratory and
others demonstrates that arginine methylation mediates growth
factor signaling through PRMT1, a type I enzyme that catalyzes
ω-NG,NG-asymmetric dimethylation (26, 28). Derynck and co-
workers showed that PRMT1-mediated arginine methylation of
cytoplasmic Smad proteins is essential for BMP and TGF-β sig-
naling (51, 52). Similarly, we found that PRMT1 was required for
Wnt signaling, catalyzing arginine methylation of cytosolic sub-
strates that become sequestered in endolysosomes (1). These data
challenge the view that methylation mostly operates in the nu-
cleus. Despite the importance of PRMT1 in cell signaling, rela-
tively little is known about the regulation of cytoplasmic arginine
methylation.
Methionine availability dictates SAM levels, which in turn
directly impacts PRMT activity (53). The methyltransferase in-
hibitor adenosine-2′,3′-dialdehyde (Adox), strongly inhibits PRMT1
relocalization into endolysosomes by Wnt (1). To investigate
whether the loss of methionine similarly decreased the sequestra-
tion of PRMT1, cells were stained with PRMT1 and GSK3 anti-
bodies and subjected to protease protection immunofluorescence
analyses. Wnt3a led to the relocalization of PRMT1 into large
endolysosomal vesicles that also contained GSK3 (Fig. 2 A and B)
(1). Methionine depletion dramatically decreased Wnt-induced
PRMT1 sequestration and colocalization with GSK3 in vesicles
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(Fig. 2 C and D). Quantification of this colocalization by Pearson’s
coefficient underscored the significant effect shown in Fig. 2E,
indicating that methionine is essential for PRMT1 endolysosomal
translocation.
Wnt-Induced Endocytosis Requires Methionine. Canonical Wnt is
emerging as a major regulator of the endocytic capacity of the
cell (1, 19, 54, 55). Wnt signaling increased endocytosis and ly-
sosomal digestion of BSA dequenched (BSA-DQ), a marker of
nonreceptor-mediated endocytosis that fluoresces only after
endocytosed BSA is digested in lysosomes (Fig. 2L) (1, 49). We
next evaluated whether Wnt-induced BSA-DQ endocytosis and
degradation after Wnt treatment was dependent on methionine
levels. Wnt3a addition for 30 min increased BSA-DQ endocy-
tosis into lysosomes in methionine-containing medium while
methionine depletion significantly diminished BSA-DQ fluores-
cence (Fig. 2 F–H andM). To study the molecular requirements of
Wnt-induced endocytosis, we next incubated cells with siRNA
targeting PRMT1 and assessed endolysosomal activity during Wnt
signaling. Comparison of cells treated with scrambled control
siRNA (siCtr) or siPRMT1 showed greatly reduced endocytosis
and lysosomal degradation of BSA (Fig. 2 I–K, quantitated in Fig.
2N), supporting the idea that PRMT1 is critical for Wnt endocy-
tosis. Together, these data indicate that PRMT1 and methionine
are required for Wnt-induced endolysosomal activity.
SAM Addition Rescues Endocytosis and Wnt Signaling. The response
to methionine starvation underscores the plasticity of metabo-
lism that allows cells to dynamically adapt to stresses such as
nutrient depletion (53). To directly test whether methionine
levels regulate Wnt signaling through SAM, the methyl cofactor
for PRMT1, we first examined whether SAM was sufficient to
rescue the effects of methionine depletion on Wnt signaling. SAM
added to the culture medium at high concentrations has been
shown to enter cultured cells (36, 56). We incubated HeLa cells in
medium with or without methionine and examined the effects of
SAM addition on vesicle formation and protein sequestration. The
lack of vesicle formation observed during methionine depletion
was completely rescued in the presence of 1 mM SAM following
Wnt3a treatment (Fig. 3 A, E, and I). Further, the translocation of
PRMT1 and GSK3 inside protease-protected vesicles during Wnt
activation was also completely rescued when cells were incubated
with SAM (Fig. 3 A–L; quantitated in Fig. 3M).
We next examined the effect of SAM addition on canonical
Wnt signaling using the BAR/β-catenin luciferase reporter assay.
Cells were incubated in medium with or without methionine,
stimulated with Wnt3a, and supplemented with SAM. Wnt/
β-catenin signaling in the absence of methionine was markedly
increased by SAM addition to the culture medium (Fig. 3N).
This indicated that the effects of methionine depletion on the
Wnt pathway were mediated by a deficiency in SAM, the uni-
versal methyl donor. This also indicates that the inhibition of
Wnt signaling by lowering methionine was not caused indirectly
by a generalized defect in protein synthesis, since it could be
replaced by a downstream metabolite. Intriguingly, SAM led to a
twofold increase in Wnt signaling compared with cells without
Fig. 1. Methionine depletion inhibits Wnt signaling. (A) The universal co-
factor for methylation SAM is generated through a biochemical mechanism
known as the methionine cycle. Methionine is converted into SAM through
an ATP-driven reaction. Methyltransferases use SAM as a cofactor to transfer
methyl groups (in red) to a myriad of substrates, generating the byproduct
SAH. SAH is rapidly converted to homocysteine, which can become reme-
thylated to form methionine, completing the cycle. (B) Experimental design
used for testing the effect of methionine deprivation on Wnt-induced en-
docytosis. Cultured cells were preincubated in methionine-depleted medium
for 30 min and then treated with Wnt3a for 30 min (in the case of HeLa cell
phase microscopy analyses or in situ protease protection assays) or 12 h (for
HEK293T BAR/β-catenin luciferase assays). (C–F) Treatment with Wnt3a for
30 min triggered the formation of large puncta visualized by phase mi-
croscopy in HeLa cells; methionine depletion for 30 min strikingly inhibited
vesicle formation in the presence of Wnt3a (compare D to F); the indicated
stippled rectangles were enlarged. (G) Enlargements of Wnt3a-induced
vesicles (2–5 μm in diameter) which were absent minus methionine. (H)
Quantification of the diameters of Wnt-induced vesicles using ImageJ. (I)
Time-course analysis of methionine depletion for 30, 60, 120, or 240 min
followed by 30 min of Wnt3a signaling; note the significant decrease in
vesicle formation after only 30 min (despite using nondialyzed serum in this
case). (J–M) Wnt-induced GSK3 sequestration inside vesicles was inhibited by
methionine starvation for 30 min, as assessed by in situ proteinase K pro-
tection assay (compare K to M). (N) Methionine depletion inhibited Wnt
signaling in BAR luciferase reporter assays, while methionine readdition in
column 4, rescued Wnt inhibition. Wnt luciferase reporter (BAR) was nor-
malized using Renilla (49). (Scale bars: 10 μm.) **P < 0.01; n < 3.
Albrecht et al. PNAS | February 19, 2019 | vol. 116 | no. 8 | 2989
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SAM even in the absence of methionine (Fig. 3N, lane 4). Per-
haps the rapid endocytosis induced by Wnt may facilitate SAM
incorporation into the cell (57).
Nicotinamide as a Methyl Sink. Beyond the one-carbon metabolic
pathway, additional metabolites can be exploited to alter global
cellular methylation by directly affecting SAM concentrations
(58). Nicotinamide (NAM, also known as vitamin B3) is the
precursor to NAD+ and has been reported to act as a “methyl
sink” to decrease SAM levels, draining methyl units from the
cytoplasm to produce 1-methyl-NA (1MNA) (Fig. 3O) (59, 60).
To examine whether decreasing SAM levels in this way would
also affect Wnt signaling, we performed Wnt luciferase assays in
permanently transfected BAR reporter HEK293T cells following
treatment with nicotinamide. Compared with control cells, nic-
otinamide significantly decreased Wnt signaling activity (Fig. 3P).
Fig. 2. Wnt-induced endocytosis and lysosomal activity require methionine and PRMT1. (A–D) Methionine depletion inhibited PRMT1 sequestration into GSK3-
containing vesicles by Wnt3a treatment in in situ protease protection analyses (compare B to D). (E) PRMT1 and GSK3 colocalization in vesicles quantified by
Pearson’s correlation coefficient using ImageJ. (F–H) Methionine depletion decreased Wnt-induced endolysosomal activity, assessed by the endocytosis and di-
gestion of BSA-DQ. (I–K) PRMT1 depletion with siRNA (siPRMT1) decreased Wnt3a-induced lysosomal activity compared with siScrambled control (siCtr) cells
(compare J to K), as assessed by endocytosis of BSA-DQ. (L) Diagram of the BSA-DQ assay, which is endocytosed and fluoresces only after the protein is
digested in lysosomes. (M ) Lysosomal activity quantification of BSA-DQ fluorescence per cell after 30 min of methionine depletion. (N) Wnt-induced
degradation of BSA-DQ in lysosomes requires the PRMT1 enzyme (ImageJ quantification per cell). (Scale bars: 10 μm.) **P < 0.01; n < 4.
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Taken together, the data with SAM rescue and the nicotinamide
sink strongly support a model whereby SAM levels are in-
trinsically linked to the Wnt signaling pathway by promoting
arginine methylation, sequestration of cytosolic PRMT1 and
GSK3 in MVBs (1), and increasing endocytosis and lysosomal
degradation of extracellular proteins.
Methotrexate Inhibits Wnt Signaling Through One-Carbon Metabolism.
One-carbon metabolism couples the methionine and folate cycles.
Nutrients from both cycles determine the abundance of SAM (Fig.
4A). Folic acid is a vitamin found in green foliage required for
mammalian physiology; folate deficiency leads to anemia and birth
defects such as neural tube closure defects (61–63). Before en-
tering the one-carbon pathway, folate must be reduced to dihy-
drofolate (DHF) and tetrahydrofolate (THF) by the NADPH-
dependent activity of dihydrofolate reductase (DHFR) (Fig. 4A)
(64, 65). Importantly, DHFR can be inhibited pharmacologically
by methotrexate, a folic acid analog that represents one of the
most effective chemotherapeutic agents and is used in the clinic to
treat a variety of diseases including cancer and arthritis (66). We
next investigated whether the disruption of the folate cycle could
affect Wnt signaling.
First, to assess canonical Wnt signaling, we performed BAR/
β-catenin luciferase assays in cells treated with methotrexate
(20 μM) in folate-free medium. Compared with DMSO-treated
control cells, methotrexate significantly decreased Wnt-induced
BAR activity (Fig. 4B, compare lanes 2 and 3). Importantly, the
addition of SAM (1 mM) rescued Wnt signaling in the presence
of methotrexate (Fig. 4B, lanes 3 and 4), supporting the hy-
pothesis that SAM is the key metabolite that mediates Wnt
signaling downstream of the folate pathway. To examine cell
viability, the same HEK293T cells expressing Renilla luciferase
from a constitutive promoter (49) were treated with methotrexate
(5–60 μM) using the same time frame of the luciferase reporter
assay (12 h). Cellular toxicity was significant only above 30 μM (Fig.
4C), consistent with previous findings (67). Second, endocytosis
Fig. 3. SAM addition to the culture medium rescues inhibition of Wnt signaling. (A–L) Methionine depletion decreased Wnt-induced vesicle formation and
inhibited the Wnt-induced sequestration of PRMT1 and GSK3 after 30 min of Wnt3a treatment, and this effect was rescued by the addition of 1 mM SAM to
the culture medium. (M) Quantification of the rescue of PRMT1 and GSK3 protease protection in vesicles by Pearson’s correlation coefficient. (N) Addition of
1 mM SAM increased Wnt-induced BAR luciferase activity when methionine was depleted. (O) Schematic depiction of the effect of addition of nicotinamide
(vitamin B3) to the culture medium. Nicotinamide becomes readily methylated (generating 1-methylnicotinamide) and serves as a sink to store methyl groups
and decrease SAM levels (59, 60). (P) Addition of 8 mM nicotinamide to the culture medium inhibited BAR/β-catenin luciferase activity. (Scale bars: 10 μm.)
**P < 0.01; n < 3.
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Fig. 4. Methotrexate inhibits Wnt signaling, as well as Wnt-induced endocytosis, lysosomal activity, and GSK3 and PRMT1 sequestration through the
folate cycle. (A) One-carbon metabolism is composed of the methionine and folate cycles; methotrexate (MTX) inhibits DHF from entering the cycle. (B)
Methotrexate (20 μM) inhibited Wnt signaling (12 h), as assessed by BAR-Renilla luciferase assays. Note that Wnt inhibition was rescued by the addition of SAM
(lane 4). (C) Methotrexate induced significant cellular toxicity only at concentrations above 30 μM in HEK293 cells stably expressing Renilla (12-h treatment with
MTX). (D–F) Methotrexate treatment inhibited Wnt-induced lysosomal activity (assessed by the fluorescence of endocytosed BSA-DQ after 30 min of Wnt3a
treatment). (G) Quantification of the inhibition of Wnt-induced endolysosomal activity by MTX using ImageJ. (H–W) MTX (20 μM) inhibited the formation of
vesicles by Wnt3a (by phase contrast microscopy) and decreased PRMT1 and GSK3 sequestration (by in situ proteinase K protection). Note that the addition of
1 mM SAM rescued the effects of MTX (arrowheads). (X) Quantification of the inhibition by MTX, and rescue by SAM, of Wnt-induced endolysosomal vesicle
formation assessed by phase contrast microscopy. (Y) Quantification of GSK3 and PRMT1 colocalization in endolysosomes/MVBs after 30 min of Wnt3a treatment
by Pearson’s correlation coefficient. (Scale bars: 10 μm.) *P < 0.05; **P < 0.01; n < 3.
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and BSA degradation was investigated in cells preincubated with
20 μM methotrexate (2 h) and subsequently treated with Wnt3a.
Methotrexate inhibited Wnt-induced endocytosis and lysosomal
degradation of BSA-DQ (Fig. 4 D–F, quantitated in Fig. 4G).
Further, in situ protease protection assays indicated that both the
formation of vesicles and the sequestration of GSK3 and PRMT1
were significantly inhibited following Wnt treatment in the pres-
ence of methotrexate (Fig. 4 H–W; quantified in Fig. 4X). Thus,
folate cycle fluctuations have a similar effect as methionine de-
pletion or nicotinamide addition described above. SAM addition
to methotrexate-treated cells completely restored endolysosomal
formation and vesicular localization of PRMT1 and GSK3 (Fig. 4
T–Y), indicating that the effects of methotrexate are through
SAM. These data imply a role for the folate pathway in Wnt-
regulated endolysosomal protein catabolism.
Discussion
One-Carbon Metabolism and Canonical Wnt. We report that one-
carbon metabolism can relay nutritional status of the cell to growth
factor signaling through the levels of methionine and SAM. Me-
thionine is required for Wnt-induced endolysosomal activity
through the generation of SAM, which fosters the sequestration of
PRMT1 and GSK3 inside late endosomes/MVBs. As Wnt signal-
ing increases the endocytosis of extracellular proteins and the ac-
tivity of lysosomes, two elements central for the regeneration of
nutrients during cell growth, targeting this mechanism may provide
a viable approach to decrease metabolic adaptations in Wnt-driven
cancers. Methotrexate was introduced in 1948 by Farber and Di-
amond (64) and was one of the first chemotherapeutic agents
targeting rapidly dividing cells. The regulation of Wnt signaling
through one-carbon metabolism uncovered here identifies mul-
tiple attractive prospects for potential therapeutic intervention.
We propose that antagonizing Wnt signaling through the dis-
ruption of one-carbon metabolism by antifolate therapies like low-
dose methotrexate, dietary alterations to reduce methionine levels,
or oral administration of SAM-depleting metabolites (methyl
sinks) such as nicotinamide (59, 68) could provide novel ap-
proaches to target Wnt-driven diseases such as familial adeno-
matous polyposis (FAP) and colon cancer (69–73). Mutations of
the APC and Axin tumor suppressors may increase endocytosis
(19, 72), as is the case with Wnt protein treatment (1). Other tumor
suppressors that can activate the Wnt pathway are RNF43 or
ZNRF3, which are potent transmembrane ubiquitin ligases that
remove the Fzd and LRP6 coreceptors from the plasma membrane
(while being themselves transcriptionally activated by nuclear
β-catenin) (2). These transmembrane proteins are antagonized by
the extracellular proteins R-spondins 1–4. The overexpression of
R-spondin 2 or 3 through DNA translocations also cause cancer by
inhibiting RNF43/ZNRF3 (2). Thus, progression of cancers caused
by mutations in APC, Axin1, Axin2, RNF43, ZNRF3, and R-
spondin 2 or 3 might be targeted by inhibiting endocytosis with
methotrexate or methionine deprivation. The situation may be
different for mutations stabilizing β-catenin (which interfere with
GSK3 phosphorylation and degradation) that act at a transcrip-
tional level, unless a β-catenin downstream transcriptional program
that regulates endocytosis exists.
In intestinal tissue, Wnt signals drive a glycolytic gradient that
corresponds with Wnt signaling, being highest at the base of the
crypt and lowest at the top of the villi, respectively (2, 74, 75).
Similarly, PRMT1 protein expression is also maximal in regions
of high Wnt activity in the crypt where it is required for intestinal
stem cell maintenance (30, 33, 76). There is evidence in the lit-
erature that one mechanism of action for methotrexate (Fig. 4A)
is through the depletion of the methylation cofactor SAM (77–
79). Thus, low-dose methotrexate could provide an already well-
characterized pharmaceutical to target the PRMT1–Wnt axis in
benign colon polyps and prevent colon cancer progression (72,
80, 81). Recent studies have identified key off-target effects
contributing to cell death during methotrexate treatment such as
histidine catabolism (82). As SAM metabolism exhibits flexibility
in response to diet (42, 56, 83), dietary alterations to increase
consumption of low-methionine foods (vegetable-based nutri-
ents) (43, 84) or supplementation to increase histidine and nico-
tinamide (vitamin B3) (68) could aid in the efficacy of methotrexate
treatment and reduce methylation in Wnt-driven disease. Folic
acid, which in the United States is added as a supplement to many
foods (such as bread) to prevent neural tube defects (85) may have
a counterbalancing effect in the diet.
Arginine Methylation as a Metabolic Sensor.Our study builds on the
recent discovery that dietary methionine has the capacity to alter
physiology through cellular methylation (56, 58, 59, 61, 62). We
found that methionine starvation or nicotinamide treatment,
which act as a cellular sink for methyl groups to decrease SAM
(59), reduced Wnt signaling in cultured cells. As phospholipids
also store methyl groups to decrease SAM (58, 84), future work
to identify other methyl-sink metabolites could offer specialized
therapeutic intervention of one-carbon metabolism. The possi-
bility that endolysosomes could operate as a sink for methyl
groups to decrease cytoplasmic SAM has never been investigated.
This tantalizing concept should warrant future investigations based
on two findings. First, we recently reported that endolysosomes
dramatically accumulate methyl arginines in proteins sequestered by
Wnt treatment (1). Second, SAM is present in lysosomes, which
also contain unusually high concentrations of arginine (86–88).
Future work evaluating if MVBs provide a repository for methyl-
ation could offer unexpected insights in the regulation of one-
carbon metabolism.
Materials and Methods
Antibodies and Reagents. Antibodies were obtained from the following
sources: mouse monoclonal antibody against PRMT1 (sc-59648, 1:500; Santa
Cruz Biotechnology) and antibody against GSK3 (610201, 1:500; BD Biosci-
ences). BSA-DQ (D-12051, Thermo Fisher Scientific) was used to monitor ly-
sosomes and fluid-phase endocytosis (49). Secondary antibodies Alexa
488 and 568 conjugated were purchased from Invitrogen. Cell culture re-
agents included DMEM, RPMI 1640 (Sigma-Aldrich, 11875093), RPMI
1640 methionine-free (Sigma-Aldrich, 1451701), RPMI 1640 folate-free
(Sigma-Aldrich, 27016021), and dialyzed FBS (Invitrogen, 26400044). Folate
and methionine were purchased from Sigma-Aldrich. The BioT transfection
reagent (Bioland Scientific) was used for siRNA knockdown and over-
expression in cultured cells. Reagents for protease protection assays were
digitonin (Abcam), proteinase K (Invitrogen), and Triton X-100 (Sigma-
Aldrich). Mounting medium for coverslips on slides was from Life Technol-
ogies, P36931. Chemical reagents used in this study included SAM (Cayman
Chemical, 13956), methotrexate (Sigma-Aldrich, A6770), cycloheximide
(Sigma-Aldrich, C7698), and nicotinamide (Sigma-Aldrich, N7559). Wnt3a
was purchased from PeproTech (315-20).
Methionine Depletion and Nicotinamide Experiments. Briefly, cells were grown
in DMEM or RPMI 1640 supplemented with 10% FCS, glutamine, and
100 units/mL penicillin. For immunofluorescence methionine depletion ex-
periments, HeLa cells were plated on coverslips at a density of 60% and
incubated in either normal RPMI or methionine-free RPMI for the indicated
times, with or without 100 ng/mL Wnt3a for 30 min. For luciferase assays,
HEK293T cells stably transfected with BAR/Renilla DNA (49) were plated onto
12 wells and methionine depletion was performed over a 12-h time course,
with or without Wnt3a (100 ng/mL) stimulation. Methionine depletion was
performed with methionine-free RPMI 1640 supplemented with 10% of ei-
ther dialyzed or nondialyzed FCS; both gave similar results. Nicotinamide has
been previously reported to reduce SAM levels (59). Luciferase assays were
performed in cells treated with nicotinamide (8 mM) with or without Wnt3a
for 12 h.
Methotrexate Experiments. Folate cycle inhibition with methotrexate (20 μM)
was performed in HeLa cells for 1 h in folate-free RPMI medium 1640, before
adding Wnt3a and assessing by immunofluorescence analyses. Cells dis-
played normal morphology. BAR-Renilla HEK293T cells were used to mea-
sure Wnt/β-catenin activity in the presence of 20 μM methotrexate after
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preincubation for 2 h in folate-free RPMI medium 1640 followed by over-
night treatment with Wnt3a for 12 h. Cellular toxicity was assessed at
methotrexate concentrations ranging from 5 μM to 60 μM.
Rescue Experiments. Methionine depletion and methotrexate treatments
were rescued by adding 1 mM SAM. For immunofluorescence assays, plated
cells were incubated with methotrexate or in methionine-free medium for
2 h. The addition of 1 mM SAM to plated cells was performed for 30 min
before Wnt3a stimulation for 30 min. For luciferase assays, cells were pre-
incubated with methotrexate or methionine-free medium for 2 h before the
addition of 1 mM SAM, and subsequently treated with Wnt3a protein (12 h).
For rescue experiments with methionine, cells were incubated in methionine-
depleted RPMI medium for 12 h and subsequently in standard RPMI
1640 for 12 h.
Cell Lines and Tissue Culture. HeLa and HEK293T were cultured in DMEM or
RPMI 1640 supplemented with 10% FCS (GIBCO), 1% penicillin, and 1%
glutamine. Cells were maintained at 37 °C and 5% CO2.
Plasmids. Plasmids used in this study were BAR-luciferase and Renilla (under
the control of the elf1a promoter) reporters, a generous gift from Randall
Moon, University of Washington, Seattle. Human PRMT1 siPRMT1 oligos (1)
(sc-41069; Santa Cruz Biotechnology) targeted three regions with the fol-
lowing sequences: (i) 5′-gcaactccatgtttcataa-3′; (ii) 5′-gttccagtatctctgatta-3′;
and (iii) 5′-cgacatgtcttgcatcaaa-3′. The negative control was Scrambled
siRNA (D-001810, Thermo Fisher Scientific).
Wnt Treatments. Recombinant murine Wnt3a protein (PeproTech, 315-20)
was used for Wnt signaling studies (100 ng/mL). For protease protection
studies, cells processed after 30 min of Wnt3a treatment at 37 °C. For lu-
ciferase assays, Wnt3a was added for 12 h.
Protease Protection and Endocytosis Assays. In situ protease protection assays
were performed to determine whether proteins were contained within
membrane-bounded organelles as described previously (1). Briefly, cells were
incubated with Wnt3a for 30 min, placed on ice, washed twice with PBS,
incubated with 6.5 μg/mL digitonin in PBS for 15 min on ice, washed twice
with ice-cold PBS to remove digitonin, and subsequently incubated with
proteinase K (1 μg/mL) for 10 min (1). PFA fixation stopped the reaction and
immunofluorescence preparation was performed as described below. To
measure endocytosis and lysosomal activity following Wnt activation, we
used BSA-DQ. Cells were plated onto 12-well dishes (60% confluency) and
incubated with 5 μg/mL of BSA-DQ in the presence or absence of Wnt3a.
Endocytosis was measured as the intensity of fluorescence from lysosome-
digested BSA-DQ. For immunofluorescence analyses, cells plated on 12-well
dishes were incubated with BSA-DQ for 30 min in the presence or absence of
Wnt3a. Cells were subsequently washed with PBS and subjected to standard
immunofluorescence processing which included fixation with 4% PFA for
15 min at room temperature in the dark, washing with PBS, and mounting
with ProLong Gold antifade reagent with DAPI (Life Technologies).
Immunofluorescence Assays. Immunofluorescence analyses were performed
as described previously (1). In short, cells were grown in 10-cm dishes and
replated onto 12-well dishes containing glass coverslips. Cells were allowed
to attach to coverslips for 24 h before Wnt treatment. Cells were washed
twice with PBS to remove medium, fixed in 4% (wt/vol) PFA (P6148, Sigma)
in PBS for 20 min, and permeabilized with 0.2% (vol/vol) Triton X-100 in PBS
for 10 min on ice. Next, coverslips were washed with PBS, blocked for 1 h in
BSA blocking buffer composed of 5% (vol/vol) goat serum plus 0.5% (wt/vol)
BSA at room temperature, and incubated with primary antibodies in
blocking buffer overnight at 4 °C (1:100–1:1,000, diluted in blocking buffer).
Finally, cells were washed three times with PBS, incubated with secondary
antibodies produced in donkey for 45 min (1:1,000, diluted in blocking
buffer), and mounted onto glass slides in ProLong Gold antifade reagent
with DAPI (Life Technologies) to stain cell nuclei. Images were acquired on a
Zeiss Imager Z.1 microscope with Apotome using a 63× oil immersion ob-
jective. Zeiss and ImageJ (NIH) imaging software were used for image
analyses. The excitation filters used to capture the images were 488 nm,
568 nm, and 405 nm (DAPI) using Alexa 568- and Alexa 488-conjugated
secondary antibodies.
Statistical Analyses and Image Quantification. For the statistical analyses
shown here, two-tailed t tests were used for two-sided comparisons, and
*P < 0.05, **P < 0.01, and ***P < 0.001 were considered to be statistically
significant. To quantitate the increased size in vesicles formed during Wnt
signaling, light microscopy [differential interference contrast microscopy
(DIC)] images were used to measure the size (diameter) of vesicles in dif-
ferent conditions using Zeiss (Zen) imaging software. The number of vesicles
formed was quantified from the DIC images using computer-assisted particle
analysis in ImageJ software, as described previously (1). Individual channels
were first given thresholds using MaxEntropy, available in the FIJI ImageJ
software package. Next, individual vesicles were separated using the binary
watershed function and vesicles were counted using the analyze particles
function at particle size 0.2–7 μm, circularity −1. More than 25 cells were
counted per experiment, numbered, and outlined copied to a spreadsheet.
Kinetics of vesicle formation were quantified in methionine-free medium
(incubation times between 5 and 240 min) and in methotrexate-treated cells
(1 h) using the DIC images from varying conditions. PRMT1 and GSK3 are
cytoplasmic proteins that become colocalized following sequestration into
vesicles during Wnt signaling (1). As such, Pearson’s correlation coefficients
were calculated using ImageJ software to assess the degree of colocalization
between two different channels (n > 20 cells per condition). For quantita-
tively analyzing BSA-DQ endocytosis, fluorescence was quantified in control
and Wnt3a-treated cells using ImageJ software analyses (n > 20 cells per
condition). Briefly, this includes normalizing fluorescence in images and
measuring fluorescence in individual cells. Results from three or more in-
dependent experiments were presented as the mean ± SEM.
Detailed protocols for measuring endocytosis, lysosomal activity, methi-
onine depletion, luciferase reporter assays, and media compositions are
provided in SI Appendix.
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